GREY:TSTIF - Post by User
Comment by
Blue_Skyon Sep 12, 2018 12:02pm
153 Views
Post# 28605344
RE:RE:RE:RE:RE:RE:RE:RE:Buy here
RE:RE:RE:RE:RE:RE:RE:RE:Buy hereStraight from the company's financial reports...For the second quarter of 2018, revenues equalled $0.4 million, as compared to $4.6 million in the second quarter of 2017. TSO3 revenues in the second quarter of 2018 reflect sales of consumables, accessories and service parts. The Company did not ship new sterilizers to Getinge in the second quarter of 2018 as opposed to 40 in the same period last year. For the six-month period ended June 30, 2018, revenues equalled $0.6 million, as compared to $8.8 million for the same period in 2017. Sales of the Company’s proprietary consumables, accessories and service parts in the second quarter and six-month period of 2018 were higher compared to the same period in 2017, reflecting increased installations of its STERIZONE® VP4 Sterilizers in medical facilities. The Company did not ship STERIZONE® VP4 Sterilizers to Getinge, nor did it receive a purchase order for such sterilizers, in the first six-month of 2018 as compared to 76 units shipped in 2017.
I'm not sure I can answer your question any better than that Cash. There have been no updates since the vQ2 results reported so how can anyone forecast they have made any sales? RR has yet to make a sale independently post the Getinge distribution Agreement changes back in January as far as I am concerned . This means sourced by a TSO3 fulltime employee, shipped, delivered, installed and booked on the income statement. Please prove to me otherwise? Why does this man still have a job at our company? The leadership and results at this company have been appaling! Shareholders should speak up and demand a change.